Arcellx (ACLX)

• Market cap: $5.18B
• 1 day: -0.06%
• 5 days: 3.38%
• 1 month: 3.23%
• 3 months: 25.26%
• 6 months: 47.95%
• Year to date: 13.74%
• 1 year: 2.69%
• 5 years: 433.15%
• 10 years: 433.15%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163